Detalles de la búsqueda
1.
Tocilizumab administration in cytokine release syndrome is associated with hypofibrinogenemia after chimeric antigen receptor T-cell therapy for hematologic malignancies.
Haematologica
; 2024 Mar 28.
Artículo
en Inglés
| MEDLINE | ID: mdl-38546698
2.
CSPG4 as Target for CAR-T-Cell Therapy of Various Tumor Entities-Merits and Challenges.
Int J Mol Sci
; 20(23)2019 Nov 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-31779130
3.
CSPG4-Specific CAR T Cells for High-Risk Childhood B Cell Precursor Leukemia.
Int J Mol Sci
; 20(11)2019 Jun 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31195686
4.
The siRNA-mediated downregulation of PD-1 alone or simultaneously with CTLA-4 shows enhanced in vitro CAR-T-cell functionality for further clinical development towards the potential use in immunotherapy of melanoma.
Exp Dermatol
; 27(7): 769-778, 2018 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29704887
5.
RNA-transfection of γ/δ T cells with a chimeric antigen receptor or an α/ß T-cell receptor: a safer alternative to genetically engineered α/ß T cells for the immunotherapy of melanoma.
BMC Cancer
; 17(1): 551, 2017 Aug 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-28818060
6.
All-oral low-dose chemotherapy TEPIP is effective and well-tolerated in patients with peripheral T-cell lymphoma.
Front Oncol
; 13: 1177330, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-37305564
7.
Biomodulatory therapy induces durable remissions in multi-system Langerhans cell histiocytosis.
Leuk Lymphoma
; 63(12): 2858-2868, 2022 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-35819881
8.
Continuous Complete Remission in Two Patients with Acute Lymphoblastic Leukemia and Severe Fungal Infection Following Short-Term, Dose-Reduced Chemotherapy.
Front Pharmacol
; 12: 599552, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34149402
9.
Biomodulatory Treatment Regimen, MEPED, Rescues Relapsed and Refractory Classic Hodgkin's Disease.
Front Pharmacol
; 12: 599561, 2021.
Artículo
en Inglés
| MEDLINE | ID: mdl-34220492
10.
Enhancing lentiviral transduction to generate melanoma-specific human T cells for cancer immunotherapy.
J Immunol Methods
; 472: 55-64, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31207210
11.
Arming T Cells with a gp100-Specific TCR and a CSPG4-Specific CAR Using Combined DNA- and RNA-Based Receptor Transfer.
Cancers (Basel)
; 11(5)2019 May 20.
Artículo
en Inglés
| MEDLINE | ID: mdl-31137488
12.
Chimeric Antigen Receptors in Different Cell Types: New Vehicles Join the Race.
Hum Gene Ther
; 29(5): 547-558, 2018 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29320890
Resultados
1 -
12
de 12
1
Próxima >
>>